Stockscreener 앱 받기
0.7786
3.22%
-0.0259
시간 외 거래:
.77
-0.0086
-1.10%
전일 마감가:
$0.8045
열려 있는:
$0.781
하루 거래량:
114.43K
Relative Volume:
0.50
시가총액:
$6.34M
수익:
$11.67M
순이익/손실:
$-2.79M
주가수익비율:
-2.0582
EPS:
-0.3783
순현금흐름:
$-2.55M
1주 성능:
-18.51%
1개월 성능:
-37.71%
6개월 성능:
-70.05%
1년 성능:
-72.05%
1일 변동 폭
$0.734
$0.781
1주일 범위
$0.734
$0.9231
52주 변동 폭
$0.7033
$3.25
Nexgel Inc Stock (NXGL) Company Profile
명칭
Nexgel Inc
전화
215 702-8550
주소
2150 CABOT BLVD WEST,, LANGHORNE
Compare NXGL vs ISRG, BDX, ALC, MDLN, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NXGL
Nexgel Inc
|
0.7786 | 6.55M | 11.67M | -2.79M | -2.55M | -0.3783 |
|
ISRG
Intuitive Surgical Inc
|
479.93 | 169.66B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
156.53 | 44.97B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
75.01 | 36.92B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
MDLN
Medline Inc
|
43.59 | 34.30B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
RMD
Resmed Inc
|
227.41 | 33.20B | 5.40B | 1.49B | 1.78B | 10.12 |
Nexgel Inc 주식(NXGL)의 최신 뉴스
NEXGEL to pay $15 million for Celularity regenerative biomaterial portfolio - MSN
NEXGEL to Pay $15 Million for Celularity Regenerative Biomaterial Portfolio - MyChesCo
Portfolio Recap: Can NEXGEL Inc stock double in the next year2026 Key Lessons & Real-Time Stock Price Movement Reports - baoquankhu1.vn
NEXGEL signs agreement to acquire regenerative biomaterial portfolio - MSN
Market Pulse: Whats the beta of NEXGEL Inc stock2026 Levels & Safe Swing Trade Setups - baoquankhu1.vn
Market Outlook: Can NEXGEL Inc stock double in the next year2026 Momentum Check & Advanced Technical Analysis Signals - baoquankhu1.vn
NEXGEL Signs Agreement to Acquire Regenerative Biomaterial Portfolio - MyChesCo
NexGel (NXGL) Expected to Announce Earnings on Monday - Defense World
NexGel to license, acquire regenerative biomaterial products - Investing.com Nigeria
UmzugsPreisChecker Announces 50,000 Moves Milestone - Barchart.com
NexGel, IncCommon Stock (NQ: NXGL - The Chronicle-Journal
NEXGEL secures $1.8 million financing for potential acquisition - MSN
NEXGEL discloses $15M upfront payment for Celularity portfolio By Investing.com - Investing.com India
NXGL Stock: NEXGEL Signs Deal to Triple Revenue and Turn Profitable With Acquisition of Six Commercial-Stage Regenerative Biomaterial Products - Barchart
NEXGEL discloses $15M upfront payment for Celularity portfolio - Investing.com
Celularity Reiterates Strategic Commercialization Partnership with NEXGEL Focused on Building Biomaterials Franchise with Established Commercial Products and New 510(k) Pathway Product Opportunities - The Manila Times
NEXGEL Announces Consideration Terms of Agreement to License and Acquire Portfolio of Commercial-Stage Regenerative Biomaterial Products - marketscreener.com
NEXGEL Inc and Celularity Inc License and Acquire Portfolio of Commercial-Stage Regenerative Biomaterial Products - marketscreener.com
Inside Celularity’s bet on NEXGEL to shake up wound care biomaterials - Stock Titan
Asymmetry Point LP holds 610,000 shares of NexGel (NXGL) reporting 7.49% stake - Stock Titan
Biotechnology company Celularity Inc. (NASDAQ: CELU) recently reaffirmed its strategic commercialization partnership with NEXGEL, INC. (NASDAQ: NXGL). - Bitget
NexGel to license, acquire regenerative biomaterial products By Investing.com - Investing.com Canada
NexGel Acquires Celularity Regenerative Biomaterials in Transformative Deal - TipRanks
Celularity Licenses Biomaterials Portfolio to NexGel Partner - TipRanks
NexGel to Acquire Celularity Biomaterials Assets and Exclusive License in Deal Up to $35 Million - TradingView
Deal to triple NEXGEL (NASDAQ: NXGL) revenue and add profits - Stock Titan
Celularity Sells and Licenses Biomaterials Portfolio to NexGel in Deal Worth Up to $35 Million - TradingView
NEXGEL, Inc. to Acquire Regenerative Biomaterial Portfolio from Celularity, Anticipating Tripled Revenue and Immediate Profitability - Quiver Quantitative
NEXGEL Signs Definitive Agreement to License and Acquire - GlobeNewswire
EXCLUSIVE: NexGel To Acquire Regenerative Biomaterial Portfolio From Celularity, Expects To Triple Revenue - Benzinga
NexGel secures regenerative biomaterials portfolio from Celularity in landmark transaction - MSN
2 Reasons to Like CALM (and 1 Not So Much) - Barchart.com
Inspire Medical Systems (INSP): Buy, Sell, or Hold Post Q4 Earnings? - Barchart.com
NEXGEL CEO Adam Levy to Join 6th Annual Semco Capital Networking Event in Chicago - MSN
Is NEXGEL Inc. Equity Warrant stock resilient to inflationWeekly Trade Summary & Weekly High Return Opportunities - Naître et grandir
NEXGEL Expands Partnership With STADA, Secures $1 Million to Fuel New Product Launches - MSN
NexGel, Inc. Stock Plummets to New 52-Week Low of $1.04 - Markets Mojo
Stocks in play: Quarterhill Inc. - Barchart
Head to Head Survey: Pacific Biosciences of California (NASDAQ:PACB) and NexGel (NASDAQ:NXGL) - Defense World
NexGel, Inc. Hits New 52-Week Low at $1.05 Amidst Decline - Markets Mojo
NexGel, Inc. Stock Plummets to New 52-Week Low of $1.09 - Markets Mojo
NXGL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
NXGL Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
NexGel, Inc. Hits New 52-Week Low at USD 1.15 Amid Decline - Markets Mojo
NexGel, Inc. Hits New 52-Week Low at $1.11 Amidst Declining Performance - Markets Mojo
NXGLW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Earnings Report: Is NEXGEL Inc currently under institutional pressureRate Cut & Weekly Watchlist of Top Performers - baoquankhu1.vn
Big Picture: Is NEXGEL Inc stock a good pick for beginnersJuly 2025 Levels & Weekly Breakout Opportunity Watchlist - baoquankhu1.vn
Hedge Fund Bets: Will NEXGEL Inc outperform the market in YEARWeekly Earnings Recap & Reliable Price Breakout Alerts - baoquankhu1.vn
Gains Report: Is NEXGEL Inc stock a hidden gemM&A Rumor & High Win Rate Trade Alerts - baoquankhu1.vn
What is the cash position of NEXGEL Inc.July 2025 Market Mood & Fast Entry and Exit Trade Plans - mfd.ru
Nexgel Inc (NXGL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.06%
0.65%
자본화:
|
볼륨(24시간):